Cross-cultural quality of life research in mental health conceptual approaches, assessment strategies, empirical results and potential impact

Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment

Volumn , Issue , 2007, Pages 67-98

  Bullinger, Monika ^a   Schmidt, Silke ^a   Naber, Dieter ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889977273     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-5779-3_5     Document Type: Chapter

References (98)

1. WHO. World Health Report 2002. Reducing Risk, Promoting Healthy Life. Geneva: World Health Organization, 2002.
2. Bullinger M. Quality of life-definition, conceptualization and implications: A methodologists view. Theor Surg, 1991; 6:143-148.
3. Power M, Harper A, Bullinger M. The World Health Organization WHOQOL-100: tests of the universality of Quality of Life in 15 different cultural groups worldwide. Health Psychology 1999; 18:495-505.
4. WHOQoL-Group, The. The World Health Organization Quality of Life Assessment (WHOQoL): Position paper from the World Health Organization. Social Science and Medicine, 1995; 41:1403-1409.
5. Cummins RA. Objective and subjective quality of life: An interactive model. Social Indicators Research 2000; 52:55-72.
6. Garrett M, McElroy AM & Staines A. Locomotor milestones and babywalkers: cross sectional study. British Medical Journal, 2002; 324:1494.
7. Bowling A. Measuring health: A review of quality of ife measurement scales. Buckingham/Philadelphia: Open University Press, 1997.
8. Bowling A. Measuring disease: A review of disease-specific quality of life measurement scales. Buckingham: Open University Press. 2001.
9. Diener E & Suh E M, Editors. Culture and subjective well-being. Cambridge, MA: MIT Press. 2000.
10. Diener E & Suh EM. Measuring subjective well-being to compare the quality of life of cultures. In Culture and Subjective Well-being, ed. E Diener & EM. Suh. London: The MIT Press, 2000, pp. 3-12.
11. Vitterso J, Roysamb E, Diener E. The concept of life satisfaction across cultures: Exploring its diverse meaning and relation to economic wealth. In The universality of subjective wellbeing indicators, ed. E Gullone, RA Cummins. Dordrecht/Boston/London: Kluwer Academic Publisher. 2002: pp. 81-103.
12. Zapf W. Social reporting in the 1970s and in the 1990s. Social Indicators Research, 2000; 51:1-15.
13. Zautra A & Goodhart, D. Quality of life indicators: A review of the literature. Community Mental Health Review, 1979; 4:1-10.
14. Cavelaars, AE, Kunst, AE, Geurts, JJ, Crialesi R, Grotvedt L, Helmert U, Lahelma E, Lundberg O, Matheson J, Mielck A, Mizrahi A, Mizrahi A, Rasmussen NK, Regidor E, Spuhler T. & Mackenbach JP. Differences in self reported morbidity by educational level: A comparison of 11 Western European countries. Journal of Epidemiolology and Community Health, 1998; 52:219-227.
15. Kahnemann D, Diener E & Schwarz N, Editors. Well-being: The foundations of hedonic psychology. New York: Russell Sage Foundation, 1999.
16. Sen A. Economic progress and health. In Poverty, inequality and health, ed. D. A. Leon & G. Walt. New York: Oxford University Press, 2001, pp. 333-345.
17. Sen A. Development as freedom. New York: Knopf, 1999.
18. Wilkinson RG. Unhealthy societies: The afflictions of inequality. London, England: Routledge, 1996.
19. Marmot MG, Davey Smith G, Stansfield S, Patel C, North F, Head J, White I, Brunner E & Feeney A. Health inequalities among British civil servants: the Whitehall II study. Lancet, 1991; 337:1387-93.
20. Mackenbach JP. Income inequality and population health. British Medical Journal, 2002; 324:1-2.
21. Berzon R, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Quality of Life Research 1993; 2(6):367-368.
22. Schmidt S, Bullinger M. Current issues in cross-cultural quality of life instrument development. Archives of Physical Medicine and Rehabilitation, 2003; 84:29-33.
23. Campbell I (Ed.) The quality of American life. Russel-Sage, New York, 1981.
24. Glatzer W, Zapf W. Anthropological Perspectives. The importance of culture in the assessment of quality of life. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1984; pp. 523-529.
25. Hutchinson JE. Quality of Life in ethnic groups. In: Spilker B (Ed.): Quality of Life and Pharma-economics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1996; pp. 587-595.
26. Johnson TM (1996) Cultural Considerations. In: Spilker B (Ed.): Quality of Life and Pharma-economics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1996; pp. 511-517.
27. Guarnaccia PJ. Anthropologial perspectives: The Importance of Culutre in the Assessment of Quality of Life. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition, Lippincott-Raven Publishers Philadelphia, 1996; pp. 523-528.
28. Brislin RW, Lonner WJ, Thorndike RM. Cross-cultural research methods. New York: John Wiley, 1973.
29. Hui C, Triandis HC. Measurement in cross-cultural psychology: a review and comparison of strategies. Cross-Cultural Psychology 1985, 16:131-152.
30. Cantrill H. The pattern of human concerns. New York: University Press, 1966.
31. Aaronson NK, Cull A, Kaasa S, Sprangers M, Acquadro C, Jambon B, Ellis D, Marquis P (1996) Language and Translation Issues. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition, Lippincott-Raven Publishers Philadelphia, 1996; pp. 575-587.
32. The European Organisation for Research and Treatment of Cancer (EORTC): Modular approach to quality of life assessment in oncology: an update. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition, Lippincott-Raven Publishers Philadelphia, 1996; pp. 179-191.
33. The European Group for Quality of Life and Health Measurement. European Guide to the Nottingham Health Profile. ESCUBASE, Montpellier, 1992.
34. Aaronson NK, Acquadro C, Alonso J, Apolone G et al. International Quality of Life Assessment (IQOLA) Project. Quality of Life Res 1, 349-351.
35. Kind P. The EuroQOL instrument: an index of health-related quality of life. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1996; pp. 191-203.
36. The WHOQOL Group. The Development of the World Health Organization Quality of Life Assessment Instrument (the WHOQOL). In: Orley J, Kuyken W (Eds.) Quality of Life Assessment: International Perspectives. Springer Berlin Heidelberg 1994, pp. 41-61.
37. Bergner M, Bobbit RA, Carter WB, Gilson BS. The Sickness Impact Profile: Development and Final Revision of a Health Status Measure. Med Care, 1981, 19, 780-805.
38. Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessment of health-related quality of life. Quality of Life Research, 1993; 2(6):369-395.
39. Cella & Bonomi. The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV Infection (FAHI) quality of life measurement system. In Quality of Life and Pharmacoeconomics in Clinical Trials 2nd edition Spilker B (ed) Philadelphia: Lippincott-Raven; 1996.
40. Cella DF, Tulsky DS, Gray G. The Functional Assessment of Cancer Therapy (FACT). Scale: Development and Validation of the General Measure. J Clin Oncol. 1993; 11:572-597.
41. Fumimoto, H; Kobayashi, K; Chang, C-H; Eremenco, S; Fujiki, Y;Uemura, S; Ohashi, Y; Kudoh, S. Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese. Qual-Life-Res. 2001; 10(8): 701-9.
42. Schipper H, Olweny CLM, Clinch JJ. A Mini-Handbook for Conducting Small-Scale Clinical Trials in Developing Countries. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1996; pp. 669-681.
43. Bullinger M, Power MJ, Aaronson NK, Cella DF, Anderson RT. Creating and Evaluating Cross-Cultural Instruments. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1996; pp. 659-669.
44. Ware Jr. JE, Gandek BL, Keller SD, and the IQOLA Project Group. Evaluating nstruments Used Cross-Nationally: Methods from the IQOLA Project. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1996; pp. 681-693.
45. Hunt SM, McEwen J, McKenna SP, Williams J, Papp E. The Nottingham Health Profile: Subjective Health Status and Medical Consultations. Sc Sci Med, 1981; 19A, 221-229.
46. Chwalow AJ. Cross-cultural validation of existing quality of life scales. Patient Education and Counseling, 1995; 26(1-3):313-318.
47. Sartorius N, Kuyken W (1994) Translation of Health Status Instruments. In: Orley J, Kuyken W (Eds.) Quality of Life Assessment: International Perspectives. Springer Berlin Heidelberg, 1994; pp. 3-19.
48. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaption of health-related quality of life measures: literature review and proposed guidelines. Journal of Clinical Epidemiology, 1993; 46(12):1417-1432.
49. Acquadro C, Jambon B, Ellis D, Marquis P. Language and Translation Issues. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition, Lippincott-Raven Publishers Philadelphia, 1996; pp. 575-587.
50. Guyatt GH The philosophy of health-related quality of life translation. Quality of Life Research, 1993; 2(6):461-465.
51. Kohlmann T, Bullinger M, & Kirchberger-Blumstein I. Die deutsche Version des Nottingham Health Profile (NHP). Übersetzungsmethodik und psychometrische Validierung. Soz Praventivmed, 1997; 42(3), 175-185.
52. Sartorius N. A WHO method for the assessment of health-related quality of life (WHOQoL). In Quality of life assessment: Key issues in the 1990s, ed. S. R. Walker & R. M. Rosser. Boston: Kluwer, 1993; pp. 201-207.
53. Skevington, S., Sartorius, N. Armin, M. Developing methods for assessing quality of life in different cultural settings. The history of the WHOQOL instruments: Social Psychiatry and Psychiatric Epidemiol., 2004; 39(1):1-8.
54. Orley J & Kyuken, W. (Eds). Quality of Life Assessment: International Perspectives. Heidelberg, Springer Verlag, 1994.
55. Ware JE, Gandek B, Kosinski MA, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M & Thunedborg K. The equivalence of SF-36 summary health scores estimated using standard and country-specific agorithms in 10 countries: Results from the IQoLA Project. Social Science and Medicine, 1998; 51:1167-1170.
56. Ware JE, Kosinski MA, Gandek BL, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L & Sullivan M. The factor structure of the SF-36 health survey in 10 countries: Results from the IQoLA Project. International quality of life assessment. Journal of Clinical Epidemiology, 1998; 51:1159-1165.
57. Fukuhara S, Ware JE, Kosinski MA, Wada S & Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol, 1998; 51:1045-1054.
58. Hall GC & Maramba GG. In search of cultural diversity: recent literature in cross-culutral and ethnic minority psychology. Cultur Divers Ethn Minor Psychol, 2001; 7:12-26.
59. The WHOQOL-Group. The World Health Organization Quality of Life Assessment (WHOQOL): Development and General Psychometric Properties. Social Science and Medicine, 1998; 46: 1569-85.
60. The WHOQOL-Group. Development of The World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychological Medicine, 1998; 28:551-8.
61. Saxena S, Carlson D, Billington R. & WHOQoLGroup. The WHO quality of life assessment instrument (WHOQoL-Bref): the importance of its items for cross-cultural research. Quality of Life Research, 2001; 10:711-721.
62. Bullinger M, Schmidt S, Petersen C, The-DISABKIDS-Group. Assessing quality of life of children with chronic health conditions and disabilities: A European approach. International Journal of Rehabilitation Research, 2002; 25:197-206.
63. Ravens-Sieberer U. Der Kindl-R Fragebogen zur Erfassung der gesundheitsbezogenen Leben-squalität bei Kindern und Jugendlichen- Revidierte Form. In Diagnostische Verfahren zu Leben-squalität und Wohlbefinden, ed. J. Schumacher, A. Klaiberg & E. Brähler. Göttingen: Hogrefe, 2003; pp. 184-188.
64. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 1999; 6:1-55.
65. Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: Test of significance and descriptive goodness-of-fit measures. Methods of Psychological Research-Online, 2003; 8:23-74.
66. Schmidt S, Power M, Bullinger M. Cross-cultural analysis of relationships of health indicators across Europe: First results based on the Eurohis project. Rep. EUR/02/5041391., World Health Organisation-Regional Office for Europe, 2002.
67. WHO. The European Health Report 2002. Copenhagen: WHO Regional Office. 2002.
68. Murray CJ & Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet, 1997; 349:1436-42.
69. Murray C & Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet, 1997; 349:1347-52.
70. Davey Smith G, Charsley K, Lambert H, Paul S, Fenton S & Ahmad W. Ethnicity, health and the meaning of socio-economic position. In Understanding health inequalities, ed. H. Graham. Buckingham/Philadelphia: Open University Press, 2000.
71. Davey Smith, G., Gunnell, D. & Ben-Shlomo, Y. (2001). Life-course approaches to socio-economic differentials in cause-specific adult mortality. In Poverty, inequality and health, ed. D. A. Leon & G. Walt. New York: Oxford University Press, 2001; pp. 88-124.
72. Marmot MG. & Shipley MJ. Do socioeconomic differences in mortality persist after retirement? 25 Year follow up of civil servants from the first Whitehall study. British Medical Journal, 1996; 313:1177-80.
73. Cavelaars AE, Kunst AE, Geurts JJ, Helmert U, Lundberg O, Mielck A, Matheson J, Mizrahi A, Mizrahi A, Rasmussen N, Spuhler T & Mackenbach JP. Morbidity differences by occupational class in men in 7 European countries. International Journal of Epidemiology, 1998; 27:222-230.
74. Mackenbach JP, Kunst AE, Cavelaars AE, Groenhof F & Geurts JJ. Socioeconomic inequalities in morbidity and mortality in western Europe. The EU working group on socioeconomic inequalities in health. Lancet, 1997; 349:1655-1659.
75. Cooper, RS. Health and social status of Blacks in the US. Annual Epidemiology, 1993; 3:137-44.
76. Salant T. & Lauderdale DS. Measuring culture: a critical review of acculturation and health in Asian immigrant populations. Social Science and Medicine, 2003; 57:71-90.
77. Sartorius N, Jablensky A & Shapiro R. Cross-cultural differences in the short-term prognosis of schizophrenic psychoses. Schizophrenia Bulletin, 1978; 4:102-13.
78. Draguns JG & Tanaka-Matsumi J. Assessment of psychopathology across and within cultures: issues and findings. Behaviour Research and Therapy, 2003; 41:755-776.
79. Cheng ATA. Expressed emotion: a cross-culturally valid concept? The British Journal of Psychiatrists, 2002; 181:466-467.
80. Hupkens CL, van den Berg J & van der Zee, J. National health interview surveys in Europe: An overview. Health Policy, 1999; 47:145-168.
81. Meltzer H. Development of a common instrument for mental health. In Developing common instruments for health surveys, ed. A. Nosikov & C. Gudex. Amsterdam: IOS Press, 2003; pp. 35-60.
82. Gudex C & Lafortune G. An inventory of health and disability-related surveys in OECD countries. Paris: Organisation for Economic Co-operation and Development (OECD Labour Market and Social Policy), 2000.
83. Diener E, Diener M & Diener C. Factors predicting the subjective well-being of nations. Journal of Personality and Social Psychology, 1995; 69:851-864.
84. Diener, E., Suh, E. M., Smith, H. & Shao, L. (1995b). National differences in reported subjective well-being: Why do they occur? Social Indicators Research, 1995; 34:7-32.
85. EORG. (2003). The mental health status of the European population. Brussel: The European Opinion Research Group; written for The SANCO Directorate-General, 2003.
86. Mesquita B & Walker R. Culutral differences in emotions: a context for interpreting emotional experiences. Behaviour Research and Therapy, 2003; 41:777-793.
87. Bullinger M, & Naber D. Assessing the Quality of Life in Mental Illness. In F Henn, N Satorius, H Helmchen & M Lauter (Eds.), Contemporary Psychiatry Vol. 1, Part 2: General Psychiatry, 2000; pp. 135-150.
88. Perkins, M R; Devlin, N J; Hansen, P. The validity and reliability of EQ-5D health state valuations in a survey of Maori. Qual-Life-Res. 2004; 13(1):271-4.
89. Bowden A, Fox-Rushby J. A systematic and critial review of teh process of translation and adaptation of generic health-related quality of life measures in Africa, Asia, Eastern Europe, the Middel East, South Africa. Social Science & Medicine, 2003; 57:1289-306.
90. Herdman M, Fox-Rushby J, Badia X. A model of equivalence in the cultural adaption of HRQoL instruments: the universalist approach. Qual Life Res, 1998; 7:323-35.
91. Naber D, Moritz S, Lambert M et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res, 2001; 50:79-88.
92. Naber D, Riedel M, Klimke A et al. Randomized double blind comparison of olanzapine and clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychatr Scand, 2005; 111:106-115.
93. De Haan L, Weisfelt M, Dingemans PM et al. Psychometric properties of the subjective well-being under neuroleptics scale and the subjective deficit syndrome scale. Psychopharmacology, 2002; 162:24-28.
94. Spilker B & Revicki DA. Taxonomy of quality of life. In Quality of life and pharmaeconomics in clinical trials, ed. B Spilker. Philadelphia: Lippincott-Raven, 1996; pp. 25-31.
95. Anderson RT, Aaronson NK, Leplège AP, Wilkin D. International Use and Application of Generic Health-Related Quality of Life Instruments. In: Spilker B (Ed.): Quality of Life and Pharmaeco-nomics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1996; pp. 613-633.
96. Bernhard J, Hürny CDT, Coates A, Gelber R. Applying Quality of Life Principles in International Cancer Clinical Trials. In: Spilker B (Ed.): Quality of Life and Pharmaeconomics in Clinical Trials, second edition 1996, Lippincott-Raven Publishers Philadelphia, 1996; pp. 693-707.
97. Mathias SD, Fifer SK, Patrick DL (1994) Rapid translation of quality of life measures for international clinical trials: avoiding errors in the minimalist approach. Quality of Life Research, 1994; 3(6):403-412.
98. Cella D, Wiklund I, Shumaker SA, Aaronson NK. Integrating health-related quality of life into cross-national clinical trials. Quality of Life Research, 1993; 2(6):433-440.